The Microenvironmental Effect in the Progression, Metastasis, and Dormancy of Breast Cancer: A Model System within Bone Marrow

Despite diagnostic advances, breast cancer remains the most prevalent cancer among women in the United States. The armamentarium of treatment options for metastatic disease is limited and mostly ineffective with regards to eradicating cancer. However, there have been novel findings in the recent literature that substantiate the function of the microenvironment in breast cancer progression and the support of metastasis to tertiary sites such as bone marrow. The uncovered significance of the microenvironment in the pathophysiology of breast cancer metastasis has served to challenge previously widespread theories and introduce new perspectives for the future research to eradicate breast cancer. This paper delineates the current understanding of the molecular mechanisms involved in the interactions between breast cancer cells and the microenvironment in progression, metastasis, and dormancy. The information, in addition to other mechanisms described in bone marrow, is discussed in the paper.

[1]  Jonathan W. Uhr,et al.  Controversies in clinical cancer dormancy , 2011, Proceedings of the National Academy of Sciences.

[2]  H. Abken,et al.  IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression. , 2011, Cancer research.

[3]  A. Sica,et al.  Mechanisms linking pathogens-associated inflammation and cancer. , 2011, Cancer letters.

[4]  P. Rameshwar,et al.  Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection , 2011, Oncology reviews.

[5]  C. la Vecchia,et al.  Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle. , 2011, The oncologist.

[6]  H. Dvorak,et al.  Tumor microenvironment and progression , 2011, Journal of surgical oncology.

[7]  M. Ewen,et al.  CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. , 2011, Cancer cell.

[8]  Yanping Zhang,et al.  The role of interleukin‐12 on modulating myeloid‐derived suppressor cells, increasing overall survival and reducing metastasis , 2011, Immunology.

[9]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[10]  Steven J. Greco,et al.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. , 2011, Cancer research.

[11]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[12]  P. Dunbar,et al.  Concise Review: Human Adipose‐Derived Stem Cells: Separating Promise from Clinical Need , 2011, Stem cells.

[13]  G. Dontu,et al.  Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. , 2011, Cancer research.

[14]  J. Condeelis,et al.  Metastasis: tumor cells becoming MENAcing. , 2010, Trends in cell biology.

[15]  Kornelia Polyak,et al.  The role of the microenvironment in mammary gland development and cancer. , 2010, Cold Spring Harbor perspectives in biology.

[16]  J. Prat,et al.  Myometrial Invasion and Lymph Node Metastasis in Endometrioid Carcinomas: Tumor-associated Macrophages, Microvessel Density, and HIF1A Have a Crucial Role , 2010, The American journal of surgical pathology.

[17]  A. Sica,et al.  Convergent pathways of macrophage polarization: The role of B cells , 2010, European journal of immunology.

[18]  Lunxu Liu,et al.  The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer , 2010, BMC Cancer.

[19]  Steven J. Greco,et al.  Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF-β , 2010, The Journal of Immunology.

[20]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[21]  P. Rameshwar,et al.  Challenges in the development of future treatments for breast cancer stem cells. , 2010, Breast cancer.

[22]  P. Rameshwar.  Breast cancer cell dormancy in bone marrow: potential therapeutic targets within the marrow microenvironment , 2010, Expert review of anticancer therapy.

[23]  S. Shi,et al.  Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis , 2010, The Journal of Immunology.

[24]  R. Xiang,et al.  Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model , 2009, PloS one.

[25]  Qiongqing Wang,et al.  ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. , 2009, Genes & development.

[26]  K. Kalland,et al.  Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model , 2009, PloS one.

[27]  N. Sneige,et al.  Immunohistochemical characterization of subtypes of male breast carcinoma , 2009, Breast Cancer Research.

[28]  Steven J. Greco,et al.  RE-1–silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells , 2009, Proceedings of the National Academy of Sciences.

[29]  Sendurai A Mani,et al.  The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies , 2009, Journal of Mammary Gland Biology and Neoplasia.

[30]  D. Banerjee,et al.  Mesenchymal stem cells: flip side of the coin. , 2009, Cancer research.

[31]  Valerie M. Weaver,et al.  A tense situation: forcing tumour progression , 2009, Nature Reviews Cancer.

[32]  S. Braun,et al.  The Prognostic Impact of Bone Marrow Micrometastases in Women with Breast Cancer , 2009, Cancer investigation.

[33]  D. Banerjee,et al.  The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells. , 2008, Experimental cell research.

[34]  J. Mesirov,et al.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. , 2008, Cancer research.

[35]  S. Morrison,et al.  Uncertainty in the niches that maintain haematopoietic stem cells , 2008, Nature Reviews Immunology.

[36]  J. Talmadge,et al.  Clonal selection of metastasis within the life history of a tumor. , 2007, Cancer research.

[37]  S. Ramkissoon,et al.  Nuclear factor-kappaB is central to the expression of truncated neurokinin-1 receptor in breast cancer: implication for breast cancer cell quiescence within bone marrow stroma. , 2007, Cancer research.

[38]  P. Bourne,et al.  Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers. , 2006, Annals of clinical and laboratory science.

[39]  P. Rameshwar,et al.  SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. , 2006, Blood.

[40]  G. Dontu,et al.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.

[41]  P. Micke,et al.  Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy , 2005, Expert opinion on therapeutic targets.

[42]  Erik Sahai,et al.  Tumor cells caught in the act of invading: their strategy for enhanced cell motility. , 2005, Trends in cell biology.

[43]  P. Rameshwar,et al.  Bone Marrow Stroma Influences Transforming Growth Factor-β Production in Breast Cancer Cells to Regulate c-myc Activation of the Preprotachykinin-I Gene in Breast Cancer Cells , 2004, Cancer Research.

[44]  P. Rameshwar,et al.  Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: a model of early cancer progression. , 2004, Cancer research.

[45]  J. Segall,et al.  Intravital imaging of cell movement in tumours , 2003, Nature Reviews Cancer.

[46]  M. Habeck.  Bone-marrow analysis predicts breast-cancer recurrence. , 2000, Molecular medicine today.

[47]  T. Kuroishi,et al.  Epidemiology of breast cancer in Japan , 1995, Cancer letters.

[48]  R. Coombes,et al.  The fate of bone marrow micrometastases in patients with primary breast cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  B. Andersen,et al.  Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients. , 2011, Cellular immunology.

[50]  Yuan Yuan Wang,et al.  Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. , 2011, Cancer research.

[51]  S. Niida,et al.  Cancer esearch oenvironment and Immunology luronan Deficiency in Tumor Stroma Impairs Macrophage R fficking and Tumor Neovascularization , 2010 .

[52]  M. Bissell,et al.  Breast cancer by proxy: can the microenvironment be both the cause and consequence? , 2009, Trends in Molecular Medicine.

[53]  M. Nishimura,et al.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy , 2008, Cancer Immunology, Immunotherapy.